About FDA
Total number of cross-agency speaking engagements received by OER during the month (1)
Dictionary: Each month, FDA Centers and Offices work closely with trade association and industry-based groups to identify appropriate Agency speakers for programs that help FDA communicate strategically with industry about important Agency initiatives as well as regulatory, scientific and compliance issues. Speaker availability may be affected by competing priorities or emerging regulatory demands.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 248 |
| Nov 2011 | N/A | 77 |
| Dec 2011 | N/A | 31 |
| Jan 2012 | N/A | 45 |
| Feb 2012 | N/A | 15 |
| Mar 2012 | N/A | 56 |
| Apr 2012 | N/A | 91 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 563
Footnotes
- (1) The number of speaker engagements received was not reported out by Center until February 2011.
Office of the Commissioner
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 19 |
| Nov 2011 | N/A | 5 |
| Dec 2011 | N/A | 5 |
| Jan 2012 | N/A | 13 |
| Feb 2012 | N/A | 4 |
| Mar 2012 | N/A | 11 |
| Apr 2012 | N/A | 17 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 74
Center for Biologics and Research
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 15 |
| Nov 2011 | N/A | 1 |
| Dec 2011 | N/A | 3 |
| Jan 2012 | N/A | 11 |
| Feb 2012 | N/A | 0 |
| Mar 2012 | N/A | 4 |
| Apr 2012 | N/A | 8 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 42
Center for Drugs Evaluation and Research
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 154 |
| Nov 2011 | N/A | 35 |
| Dec 2011 | N/A | 7 |
| Jan 2012 | N/A | 6 |
| Feb 2012 | N/A | 4 |
| Mar 2012 | N/A | 16 |
| Apr 2012 | N/A | 40 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 262
Center for Devices and Radiological Health
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 30 |
| Nov 2011 | N/A | 4 |
| Dec 2011 | N/A | 3 |
| Jan 2012 | N/A | 1 |
| Feb 2012 | N/A | 2 |
| Mar 2012 | N/A | 4 |
| Apr 2012 | N/A | 6 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 50
Center for Food Safety and Applied Nutrition
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 5 |
| Nov 2011 | N/A | 3 |
| Dec 2011 | N/A | 3 |
| Jan 2012 | N/A | 3 |
| Feb 2012 | N/A | 0 |
| Mar 2012 | N/A | 1 |
| Apr 2012 | N/A | 3 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 18
Center for Tobacco Products
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 0 |
| Nov 2011 | N/A | 0 |
| Dec 2011 | N/A | 3 |
| Jan 2012 | N/A | 0 |
| Feb 2012 | N/A | 0 |
| Mar 2012 | N/A | 0 |
| Apr 2012 | N/A | 0 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 3
Center for Veterinary Medicine
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 0 |
| Nov 2011 | N/A | 1 |
| Dec 2011 | N/A | 2 |
| Jan 2012 | N/A | 0 |
| Feb 2012 | N/A | 0 |
| Mar 2012 | N/A | 2 |
| Apr 2012 | N/A | 3 |
| May 2012 | N/A | TBD |
| Jun 2012 | N/A | TBD |
| Jul 2012 | N/A | TBD |
| Aug 2012 | N/A | TBD |
| Sep 2012 | N/A | TBD |
FY 2012 YTD: 8
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







